Intrinsiqq
EssilorLuxottica SA logo

EssilorLuxottica SA Quality Score

EL.XPAR

⊜ Compare
Quality43

Business quality is the primary weakness (avg 13/100). Growth is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
40/100
38.0x

Above 30x, priced for sustained outperformance

Cash Flow Multiple
80/100
23.0x

20–25x, moderate cash flow premium

Revenue Growth
70/100
5.2%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
70/100
5.5%

5–10% CAGR, steady but not exceptional

Business Quality & Capital Allocation

Share Dilution
30/100
3.8%

Diluting 2–5%, watch for SBC

Margin Trend
20/100
-1.0pp

Modest contraction, within normal range

Capital Structure
0/100
€10.85B

Net debt/FCF of 2.9x, high leverage

2022
€1.96B
€12.2B
2023
€2.56B
€11.7B
2024
€2.25B
€11.7B
2025
€3.54B
€14.4B
CashDebt
Return on Capital
0/100
4.8%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

EssilorLuxottica SA (EL.XPAR) quality: score, margins and returns

EssilorLuxottica SA (EL.XPAR) scores 43/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 8 metrics each scored 0 to 100, on 11.9% operating margins and 4.8% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is EssilorLuxottica SA (EL.XPAR) a high-quality business?+

EssilorLuxottica SA scores 43 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a 11.9% operating margin and a 4.8% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does EssilorLuxottica SA's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from EL.XPAR's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where EssilorLuxottica SA scores well and where it falls behind.

What is EssilorLuxottica SA's return on invested capital (ROIC)?+

EssilorLuxottica SA earns about 4.8% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to EL.XPAR's margins and growth on this scorecard to judge durability.

How profitable is EssilorLuxottica SA?+

EssilorLuxottica SA runs an operating margin of about 11.9% and a net margin of about 8.6%. Revenue has grown at roughly 9.5% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Medical Instruments & Supplies · Pick stocks to compare with EL.XPAR

CompareIntrinsic value
CAP.XPARCapgemini SE
€129.50+3.43%39
EMEIS.XPAREmeis SA
€10.20+2.93%56
CLARI.XPARClariane SE
€3.31+3.43%45
GDS.XPARRamsay Générale de Santé SA
€8.62-1.37%49
ORP.XPAROrpea
€10.20+2.93%26
BIM.XPARbioMérieux SA
€97.65+3.06%65
IPN.XPARIpsen
€155.80+1.70%60
SOBI.XSTOSwedish Orphan Biovitrum AB
kr 482.00+0.31%40

Held by ETFs

EL.XPAR is in 120 US ETFs. The largest of them, with EL.XPAR's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EL.XPAR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.